Search Results - "Ahmann, Andrew J"

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline by Peters, Anne L, Ahmann, Andrew J, Battelino, Tadej, Evert, Alison, Hirsch, Irl B, Murad, M. Hassan, Winter, William E, Wolpert, Howard

“…Objective: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with…”
Get full text

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia by Bergenstal, Richard M, Klonoff, David C, Garg, Satish K, Bode, Bruce W, Meredith, Melissa, Slover, Robert H, Ahmann, Andrew J, Welsh, John B, Lee, Scott W, Kaufman, Francine R

“…In this study involving patients with type 1 diabetes, sensor-augmented insulin-pump therapy plus automated insulin suspension when glucose dropped below 70 mg…”
Get full text

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry by Wong, Jenise C, Foster, Nicole C, Maahs, David M, Raghinaru, Dan, Bergenstal, Richard M, Ahmann, Andrew J, Peters, Anne L, Bode, Bruce W, Aleppo, Grazia, Hirsch, Irl B, Kleis, Lora, Chase, H Peter, DuBose, Stephanie N, Miller, Kellee M, Beck, Roy W, Adi, Saleh

“…To assess the frequency of continuous glucose monitoring (CGM) device use, factors associated with its use, and the relationship of CGM with diabetes outcomes…”
Get full text

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes by Davis, Asa K, DuBose, Stephanie N, Haller, Michael J, Miller, Kellee M, DiMeglio, Linda A, Bethin, Kathleen E, Goland, Robin S, Greenberg, Ellen M, Liljenquist, David R, Ahmann, Andrew J, Marcovina, Santica M, Peters, Anne L, Beck, Roy W, Greenbaum, Carla J

“…It is generally accepted that complete β-cell destruction eventually occurs in individuals with type 1 diabetes, which has implications for treatment…”
Get full text

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) by Bergenstal, Richard M, Ahmann, Andrew J, Bailey, Timothy, Beck, Roy W, Bissen, Joan, Buckingham, Bruce, Deeb, Larry, Dolin, Robert H, Garg, Satish K, Goland, Robin, Hirsch, Irl B, Klonoff, David C, Kruger, Davida F, Matfin, Glenn, Mazze, Roger S, Olson, Beth A, Parkin, Christopher, Peters, Anne, Powers, Margaret A, Rodriguez, Henry, Southerland, Phil, Strock, Ellie S, Tamborlane, William, Wesley, David M

“…Abstract Underutilization of glucose data and lack of easy and standardized glucose data collection, analysis, visualization, and guided clinical decision…”
Get more information

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial by Ahmann, Andrew J, Capehorn, Matthew, Charpentier, Guillaume, Dotta, Francesco, Henkel, Elena, Lingvay, Ildiko, Holst, Anders G, Annett, Miriam P, Aroda, Vanita R

“…To compare the efficacy and safety of once-weekly semaglutide 1.0 mg s.c. with exenatide extended release (ER) 2.0 mg s.c. in subjects with type 2 diabetes. In…”
Get full text

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections by Bergenstal, Richard M, Bailey, Timothy S, Rodbard, David, Ziemen, Monika, Guo, Hailing, Muehlen-Bartmer, Isabel, Ahmann, Andrew J

“…The objective of this study was to compare glucose control in participants with type 1 diabetes receiving insulin glargine 300 units/mL (Gla-300) or glargine…”
Get full text

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes by Aleppo, Grazia, Ruedy, Katrina J, Riddlesworth, Tonya D, Kruger, Davida F, Peters, Anne L, Hirsch, Irl, Bergenstal, Richard M, Toschi, Elena, Ahmann, Andrew J, Shah, Viral N, Rickels, Michael R, Bode, Bruce W, Philis-Tsimikas, Athena, Pop-Busui, Rodica, Rodriguez, Henry, Eyth, Emily, Bhargava, Anuj, Kollman, Craig, Beck, Roy W

“…To determine whether the use of continuous glucose monitoring (CGM) without confirmatory blood glucose monitoring (BGM) measurements is as safe and effective…”
Get full text

Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy by Rosenstock, Julio, Ahmann, Andrew J, Colon, Gildred, Scism-Bacon, Jamie, Jiang, Honghua, Martin, Sherry

“…OBJECTIVE:--The purpose of this study was to compare two analog insulin therapies (prandial premixed therapy [PPT] versus basal/bolus therapy [BBT]) in type 2…”
Get full text

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus by Schwartz, Sherwyn L., MD, Rendell, Marc, MD, Ahmann, Andrew J., MD, Thomas, Asha, MD, Arauz-Pacheco, Carlos J., MD, Welles, Bernice R., MD

“…Abstract Background: Elevated levels of cortisol have been implicated in the development of type 2 diabetes mellitus and the metabolic syndrome. Modulation of…”
Get full text

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes by Weinstock, Ruth S, DuBose, Stephanie N, Bergenstal, Richard M, Chaytor, Naomi S, Peterson, Christina, Olson, Beth A, Munshi, Medha N, Perrin, Alysa J S, Miller, Kellee M, Beck, Roy W, Liljenquist, David R, Aleppo, Grazia, Buse, John B, Kruger, Davida, Bhargava, Anuj, Goland, Robin S, Edelen, Rachel C, Pratley, Richard E, Peters, Anne L, Rodriguez, Henry, Ahmann, Andrew J, Lock, John-Paul, Garg, Satish K, Rickels, Michael R, Hirsch, Irl B

“…Severe hypoglycemia is common in older adults with long-standing type 1 diabetes, but little is known about factors associated with its occurrence. A…”
Get full text

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study by Rickels, Michael R, Ruedy, Katrina J, Foster, Nicole C, Piché, Claude A, Dulude, Hélène, Sherr, Jennifer L, Tamborlane, William V, Bethin, Kathleen E, DiMeglio, Linda A, Wadwa, R Paul, Ahmann, Andrew J, Haller, Michael J, Nathan, Brandon M, Marcovina, Santica M, Rampakakis, Emmanouil, Meng, Linyan, Beck, Roy W

“…Treatment of severe hypoglycemia with loss of consciousness or seizure outside of the hospital setting is presently limited to intramuscular glucagon requiring…”
Get full text

Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial by Nathan, David M, Herman, William H, Larkin, Mary E, Krause-Steinrauf, Heidi, Abou Assi, Hiba, Ahmann, Andrew J, Brown-Friday, Janet, Hsia, Daniel S, Harindhanavudhi, Tasma, Johnson, Mary, Arends, Valerie L, Butera, Nicole M, Rosin, Samuel P, Lachin, John M, Younes, Naji

“…To determine whether the relationship between average glucose (AG) levels and hemoglobin A1c (HbA1c) differs across racial/ethnic groups. We performed a…”
Get full text

Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes by Miller, Kellee M, Kanapka, Lauren G, Rickels, Michael R, Ahmann, Andrew J, Aleppo, Grazia, Ang, Lynn, Bhargava, Anuj, Bode, Bruce W, Carlson, Anders, Chaytor, Naomi S, Gannon, Gail, Goland, Robin, Hirsch, Irl B, Kiblinger, Lisa, Kruger, Davida, Kudva, Yogish C, Levy, Carol J, McGill, Janet B, O'Malley, Grenye, Peters, Anne L, Philipson, Louis H, Philis-Tsimikas, Athena, Pop-Busui, Rodica, Salam, Maamoun, Shah, Viral N, Thompson, Michael J, Vendrame, Francesco, Verdejo, Alandra, Weinstock, Ruth S, Young, Laura, Pratley, Richard

“…To evaluate glycemic outcomes in the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) randomized clinical trial (RCT) participants during an…”
Get more information

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes by Aleppo, Grazia, Laffel, Lori M, Ahmann, Andrew J, Hirsch, Irl B, Kruger, Davida F, Peters, Anne, Weinstock, Ruth S, Harris, Dennis R

“…After reviewing previously published methods, we developed a practical approach to adjusting insulin doses based on insulin sensitivity for adult patients with…”
Get full text

Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study by Carlson, Anders L., Kanapka, Lauren G., Miller, Kellee M., Ahmann, Andrew J., Chaytor, Naomi S., Fox, Steven, Kiblinger, Lisa, Kruger, Davida, Levy, Carol J., Peters, Anne L., Rickels, Michael R., Salam, Maamoun, Shah, Viral N., Young, Laura A., Kudva, Yogish C., Pratley, Richard

“…Background: Knowledge regarding the burden and predictors of hypoglycemia among older adults with type 1 diabetes (T1D) is limited. Methods: We analyzed…”
Get full text

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults by Kudva, Yogish C, Ahmann, Andrew J, Bergenstal, Richard M, Gavin, James R, Kruger, Davida F, Midyett, L Kurt, Miller, Eden, Harris, Dennis R

“…Abstract The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals with diabetes. CGM systems provide retrospective…”
Get full text

Guidelines and performance measures for diabetes by Ahmann, Andrew J

“…Diabetes mellitus has become a major public health problem in the United States and around the world. A result of genetic predisposition combined with…”
Get full text

Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes by Los, Evan A., Ramsey, Katrina L., Guttmann-Bauman, Ines, Ahmann, Andrew J.

“…Background: We examined the reliability of trained dogs to alert to hypoglycemia in individuals with type 1 diabetes. Methods: Patients with type 1 diabetes…”
Get full text

Can trained dogs detect a hypoglycemic scent in patients with type 1 diabetes? by Dehlinger, Ky, Tarnowski, Kristin, House, Jody L, Los, Evan, Hanavan, Kathryn, Bustamante, Bryan, Ahmann, Andrew J, Ward, W Kenneth

Get full text